Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis may be a marker of undisclosed vasculitis (2007)
- Authors:
- USP affiliated authors: VIANA, VILMA DOS SANTOS TRINDADE - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; VOEGELS, RICHARD LOUIS - FM ; BUENO, CLEONICE - FM
- Unidade: FM
- Subjects: RESUMOS (SIMPÓSIOS); ANTICORPOS; RINITE; SINUSITE; DOENÇA CRÔNICA VASCULITE
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio avanços em pesquisas médicas
-
ABNT
GONÇALVES, C. et al. Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis may be a marker of undisclosed vasculitis. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 18 abr. 2024. , 2007 -
APA
Gonçalves, C., Pinaffi, J. V., Carvalho, J. F., Pinna, F. R., Constantino, G. T., Voegels, R. L., et al. (2007). Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis may be a marker of undisclosed vasculitis. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Gonçalves C, Pinaffi JV, Carvalho JF, Pinna FR, Constantino GT, Voegels RL, Viana V dos ST, Bonfá E, Bueno C. Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis may be a marker of undisclosed vasculitis. Clinics. 2007 ; 62 S169.[citado 2024 abr. 18 ] -
Vancouver
Gonçalves C, Pinaffi JV, Carvalho JF, Pinna FR, Constantino GT, Voegels RL, Viana V dos ST, Bonfá E, Bueno C. Antineutrophil cytoplasmic antibodies in chronic rhinosinusitis may be a marker of undisclosed vasculitis. Clinics. 2007 ; 62 S169.[citado 2024 abr. 18 ] - EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement?
- Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren’s syndrome
- Complement fixing activity of anticardioliin antibodies in patients with and without thrombosis
- Anti-lipoprotein lipase (LPL) antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
- Anticorpos antilipoproteina lipase (LPL): um novo componente no complexo processo aterosclerotico no lupus eritematoso sistemico?
- Complement-fixingactivity of anticardiolipin antibodies in patients with and without thrombosis
- Anticorpo anti-lipoproteína lipase e atividade do LES
- Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
- Anticorpos antiliproteína lipase (LPL): um novo componente no complexo processo aterosclerótico do lúpus eritematoso
- Antibody to a 24 kda non-granule associated protein from human neutrophil in takayasu's arteritis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
